Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Yoshihito D. Saito

Hematology Oncology | Oncology | Hematology
The Queens Medical Center
91 -2127 Fort Weaver Rd, 
Ewa Beach, HI 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Experienced in WT1-Related Wilms Tumor Syndromes
The Queens Medical Center
91 -2127 Fort Weaver Rd, 
Ewa Beach, HI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Yoshihito Saito is a Hematologist Oncology specialist and an Oncologist in Ewa Beach, Hawaii. Dr. Saito is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Breast Cancer in Men, Small Cell Lung Cancer (SCLC), Lung Cancer, and Pleuropulmonary Blastoma. Dr. Saito is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Hematology Oncology
Oncology
Hematology
Licenses
Internal Medicine in HI
Hospital Affiliations
The Queens Medical Center
Kuakini Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
AlohaCare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Hawaii Medical Assurance Association
  • PPO
HMSA
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

THE QUEENS MEDICAL CENTER
91 -2127 Fort Weaver Rd, Ewa Beach, HI 96706
Other Locations
THE QUEENS MEDICAL CENTER
91 -2135 Fort Weaver Rd, Suite 180, Ewa Beach, HI 96706
THE QUEENS MEDICAL CENTER
1380 Lusitana St, Suite 608, Honolulu, HI 96813
THE QUEENS MEDICAL CENTER
1301 Punchbowl St, Honolulu, HI 96813

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Phase III Study of Combination Osimertinib (AZD9291) and Bevacizumab Versus Osimertinib (AZD9291) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Recruiting
Publish Date: October 10, 2025
Intervention Type: Procedure, Drug, Biological
Study Drugs: Bevacizumab, Osimertinib
Study Phase: Phase 3
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
A Phase III Randomized Study of Maintenance Nivolumab Versus Observation in Patients With Locally Advanced, Intermediate Risk HPV Positive OPSCC
Enrollment Status: Suspended
Publish Date: October 10, 2025
Intervention Type: Procedure, Drug, Biological, Radiation, Other
Study Drugs: Cisplatin, Nivolumab
Study Phase: Phase 3
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
Enrollment Status: Terminated
Publish Date: October 03, 2025
Intervention Type: Drug, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Gemcitabine, Nivolumab
Study Phase: Phase 3
View 2 Less Clinical Trial

2 Total Publications

A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature.
A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature.
Journal: Journal of medical case reports
Published: February 11, 2020
Similar Doctors
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Rachna Anand
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Rachna Anand
Hematology Oncology | Hematology | Oncology

Kapiolani Medical Center For Women & Children

1319 Punahou Street, Suite 640, 
Honolulu, HI 
 (12.0 miles away)
808-983-6090
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rachna Anand is a Hematologist Oncology specialist and a Hematologist in Honolulu, Hawaii. Dr. Anand is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. Her top areas of expertise are Sideroblastic Anemia, Inflammatory Breast Cancer, Angiosarcoma, and Autoimmune Hemolytic Anemia. Dr. Anand is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jared D. Acoba
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Jared D. Acoba
Hematology Oncology | Hematology | Oncology

The Queens Medical Center

1301 Punchbowl St, 
Honolulu, HI 
 (10.6 miles away)
808-691-1000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jared Acoba is a Hematologist Oncology specialist and a Hematologist in Honolulu, Hawaii. Dr. Acoba is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Colorectal Cancer, Cholangiocarcinoma (Bile Duct Cancer), and Gastrostomy. Dr. Acoba is currently accepting new patients.

Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Melvin P. Palalay
Hematology Oncology | Hematology | Oncology
Advanced in WT1-Related Wilms Tumor Syndromes
Dr. Melvin P. Palalay
Hematology Oncology | Hematology | Oncology

American Oncology Partners Of Hawaii LLC

500 Ala Moana Blvd, Suite 6230, 
Honolulu, HI 
 (10.2 miles away)
808-524-6115
Languages Spoken:
English, Cantonese, Filipino, Ilocano, Mandarin, Samoan, Spanish, Vietnamese
See accepted insurances
Accepting New Patients
Offers Telehealth

Melvin Palalay is a Hematologist Oncology specialist and a Hematologist in Honolulu, Hawaii. Dr. Palalay is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Magnesium Deficiency, Gitelman Syndrome, Familial Colorectal Cancer, Paget Disease of the Breast, and Bone Marrow Aspiration. Dr. Palalay is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Saito's expertise for a condition
ConditionClose
    View All 13 Advanced Conditions
    View All 78 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile